| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 6.39e-06 | 11 | 69 | 3 | GO:0005388 | |
| GeneOntologyMolecularFunction | calcium-dependent ATPase activity | 7.03e-05 | 4 | 69 | 2 | GO:0030899 | |
| GeneOntologyMolecularFunction | transporter activity | PIEZO2 KCNT2 SLC44A5 APOL4 SLC37A2 KCNK6 APOD TMEM184B ATP2A1 ATP2A2 ATP2A3 CHRFAM7A SLC30A10 SLC6A14 | 1.10e-04 | 1289 | 69 | 14 | GO:0005215 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | VN1R3 OR5B3 OR4C16 OR13A1 OR4E2 OR1F2P OR1C1 GPR171 GPR101 OR4K3 HCRTR1 | 2.09e-04 | 884 | 69 | 11 | GO:0004930 |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 2.60e-04 | 36 | 69 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 2.60e-04 | 36 | 69 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | PIEZO2 KCNT2 APOL4 KCNK6 ATP2A1 ATP2A2 ATP2A3 CHRFAM7A SLC30A10 SLC6A14 | 3.76e-04 | 793 | 69 | 10 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | PIEZO2 KCNT2 KCNK6 ATP2A1 ATP2A2 ATP2A3 CHRFAM7A SLC30A10 SLC6A14 | 4.49e-04 | 664 | 69 | 9 | GO:0008324 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | VN1R3 OR5B3 OR4C16 MFSD6 OR13A1 OR4E2 OR1F2P OR1C1 GPR171 GPR101 OR4K3 CHRFAM7A HCRTR1 | 6.55e-04 | 1353 | 69 | 13 | GO:0004888 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | PIEZO2 KCNT2 SLC44A5 APOL4 SLC37A2 KCNK6 ATP2A1 ATP2A2 ATP2A3 CHRFAM7A SLC30A10 SLC6A14 | 6.60e-04 | 1180 | 69 | 12 | GO:0022857 |
| GeneOntologyMolecularFunction | olfactory receptor activity | 7.08e-04 | 431 | 69 | 7 | GO:0004984 | |
| GeneOntologyMolecularFunction | siRNA binding | 7.60e-04 | 12 | 69 | 2 | GO:0035197 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.10e-03 | 465 | 69 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | KCNT2 APOL4 SLC37A2 KCNK6 ATP2A1 ATP2A2 ATP2A3 SLC30A10 SLC6A14 | 1.15e-03 | 758 | 69 | 9 | GO:0015318 |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.23e-03 | 614 | 69 | 8 | GO:0140657 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.28e-03 | 477 | 69 | 7 | GO:0022804 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 1.29e-03 | 62 | 69 | 3 | GO:0019829 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 1.37e-03 | 16 | 69 | 2 | GO:0008179 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.86e-03 | 151 | 69 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 3.85e-03 | 301 | 69 | 5 | GO:0022853 | |
| GeneOntologyMolecularFunction | outward rectifier potassium channel activity | 3.91e-03 | 27 | 69 | 2 | GO:0015271 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 4.16e-03 | 441 | 69 | 6 | GO:0016887 | |
| GeneOntologyMolecularFunction | peptide binding | 4.86e-03 | 318 | 69 | 5 | GO:0042277 | |
| GeneOntologyBiologicalProcess | calcium ion transport from cytosol to endoplasmic reticulum | 1.10e-05 | 2 | 69 | 2 | GO:1903515 | |
| GeneOntologyBiologicalProcess | positive regulation of endoplasmic reticulum calcium ion concentration | 3.30e-05 | 3 | 69 | 2 | GO:0032470 | |
| GeneOntologyBiologicalProcess | cytosol to endoplasmic reticulum transport | 1.10e-04 | 5 | 69 | 2 | GO:0046967 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum calcium ion homeostasis | 1.23e-04 | 29 | 69 | 3 | GO:0032469 | |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 1.23e-04 | 29 | 69 | 3 | GO:1903779 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 2.85e-06 | 9 | 69 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 5.57e-06 | 11 | 69 | 3 | GO:0031094 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 1.07e-05 | 88 | 69 | 5 | GO:0016529 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 1.46e-05 | 45 | 69 | 4 | GO:0033017 | |
| GeneOntologyCellularComponent | sarcoplasm | 3.76e-05 | 114 | 69 | 5 | GO:0016528 | |
| HumanPheno | Uveitis | 1.43e-05 | 64 | 26 | 5 | HP:0000554 | |
| Domain | P-type_ATPase_IIA | 4.41e-08 | 3 | 67 | 3 | IPR005782 | |
| Domain | Hydrolase_3 | 5.20e-06 | 10 | 67 | 3 | PF08282 | |
| Domain | - | 2.39e-05 | 16 | 67 | 3 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_TM_dom | 2.39e-05 | 16 | 67 | 3 | IPR023298 | |
| Domain | ATPase_P-typ_cation-transptr_C | 2.89e-05 | 17 | 67 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 2.89e-05 | 17 | 67 | 3 | PF00689 | |
| Domain | Cation_ATPase_N | 3.46e-05 | 18 | 67 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 3.46e-05 | 18 | 67 | 3 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 4.10e-05 | 19 | 67 | 3 | IPR004014 | |
| Domain | G_PROTEIN_RECEP_F1_1 | VN1R3 OR5B3 OR4C16 OR13A1 OR4E2 OR1F2P OR1C1 GPR171 GPR101 HCRTR1 | 1.55e-04 | 685 | 67 | 10 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | VN1R3 OR5B3 OR4C16 OR13A1 OR4E2 OR1F2P OR1C1 GPR171 GPR101 HCRTR1 | 1.66e-04 | 691 | 67 | 10 | PS50262 |
| Domain | GPCR_Rhodpsn | VN1R3 OR5B3 OR4C16 OR13A1 OR4E2 OR1F2P OR1C1 GPR171 GPR101 HCRTR1 | 1.68e-04 | 692 | 67 | 10 | IPR000276 |
| Domain | - | 2.03e-04 | 32 | 67 | 3 | 3.40.1110.10 | |
| Domain | - | 2.03e-04 | 32 | 67 | 3 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 2.66e-04 | 35 | 67 | 3 | IPR023299 | |
| Domain | P_typ_ATPase | 2.89e-04 | 36 | 67 | 3 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 2.89e-04 | 36 | 67 | 3 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 2.89e-04 | 36 | 67 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 3.14e-04 | 37 | 67 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 3.14e-04 | 37 | 67 | 3 | PF00122 | |
| Domain | PH-BEACH_dom | 3.50e-04 | 8 | 67 | 2 | IPR023362 | |
| Domain | - | 3.50e-04 | 8 | 67 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 3.50e-04 | 8 | 67 | 2 | PS51783 | |
| Domain | BEACH_dom | 4.49e-04 | 9 | 67 | 2 | IPR000409 | |
| Domain | BEACH | 4.49e-04 | 9 | 67 | 2 | PS50197 | |
| Domain | Beach | 4.49e-04 | 9 | 67 | 2 | PF02138 | |
| Domain | - | 4.49e-04 | 9 | 67 | 2 | 1.10.1540.10 | |
| Domain | Beach | 4.49e-04 | 9 | 67 | 2 | SM01026 | |
| Domain | 7tm_1 | 6.69e-04 | 677 | 67 | 9 | PF00001 | |
| Domain | K_chnl_dom | 2.55e-03 | 21 | 67 | 2 | IPR013099 | |
| Domain | Ion_trans_2 | 2.55e-03 | 21 | 67 | 2 | PF07885 | |
| Domain | GPCR_Rhodpsn_7TM | 2.66e-03 | 670 | 67 | 8 | IPR017452 | |
| Domain | Olfact_rcpt | 2.83e-03 | 393 | 67 | 6 | IPR000725 | |
| Domain | HAD-like_dom | 2.87e-03 | 79 | 67 | 3 | IPR023214 | |
| Domain | ArfGap | 4.84e-03 | 29 | 67 | 2 | SM00105 | |
| Domain | ArfGap | 4.84e-03 | 29 | 67 | 2 | PF01412 | |
| Domain | ARFGAP | 4.84e-03 | 29 | 67 | 2 | PS50115 | |
| Domain | ArfGAP | 4.84e-03 | 29 | 67 | 2 | IPR001164 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA | 2.77e-06 | 8 | 53 | 3 | M47955 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.08e-05 | 12 | 53 | 3 | M27326 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.77e-05 | 14 | 53 | 3 | MM15052 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 3.93e-05 | 18 | 53 | 3 | M614 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 4.10e-05 | 103 | 53 | 5 | MM15196 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 4.90e-05 | 54 | 53 | 4 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 4.90e-05 | 54 | 53 | 4 | MM15202 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.24e-04 | 130 | 53 | 5 | M27454 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.38e-04 | 27 | 53 | 3 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.54e-04 | 28 | 53 | 3 | M924 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 3.77e-04 | 165 | 53 | 5 | MM15026 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 9.65e-04 | 203 | 53 | 5 | M5485 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 1.03e-03 | 119 | 53 | 4 | M607 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.15e-03 | 55 | 53 | 3 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.27e-03 | 57 | 53 | 3 | MM15643 | |
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 16410239 | ||
| Pubmed | The nongastric H+-K+-ATPases: molecular and functional properties. | 3.26e-08 | 4 | 71 | 3 | 10362770 | |
| Pubmed | 3.26e-08 | 4 | 71 | 3 | 25110346 | ||
| Pubmed | 1.13e-07 | 22 | 71 | 4 | 28890335 | ||
| Pubmed | Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1. | 2.84e-07 | 7 | 71 | 3 | 24786561 | |
| Pubmed | 4.53e-07 | 8 | 71 | 3 | 10951186 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 4.53e-07 | 8 | 71 | 3 | 19033399 | |
| Pubmed | Widespread control of calcium signaling by a family of SERCA-inhibiting micropeptides. | 4.53e-07 | 8 | 71 | 3 | 27923914 | |
| Pubmed | A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. | 6.79e-07 | 9 | 71 | 3 | 25640239 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 12556521 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 25270119 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 19644701 | ||
| Pubmed | Sarco(endo)plasmic reticulum Ca2+ ATPases (SERCA1 and -2) in human extraocular muscles. | 4.11e-06 | 2 | 71 | 2 | 14638697 | |
| Pubmed | Sarco(endo)plasmic reticulum Ca2+ ATPase isoforms and their role in muscle physiology and pathology. | 4.11e-06 | 2 | 71 | 2 | 10603953 | |
| Pubmed | Characterizing SERCA Function in Murine Skeletal Muscles after 35-37 Days of Spaceflight. | 4.11e-06 | 2 | 71 | 2 | 34769190 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 24610369 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 18295663 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 19650915 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 18953100 | ||
| Pubmed | SERCA overexpression reduces hydroxyl radical injury in murine myocardium. | 4.11e-06 | 2 | 71 | 2 | 16798816 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 21885870 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 19962989 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 25281535 | ||
| Pubmed | Toll-Like Receptor 9 Promotes Survival in SERCA2a KO Heart Failure Mice. | 4.11e-06 | 2 | 71 | 2 | 28490840 | |
| Pubmed | Mice doubly-deficient in the Arf GAPs SMAP1 and SMAP2 exhibit embryonic lethality. | 4.11e-06 | 2 | 71 | 2 | 26296315 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 12975374 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 15718407 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 11402072 | ||
| Pubmed | Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle. | 1.23e-05 | 3 | 71 | 2 | 27055500 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 25615793 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 9788433 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 16973504 | ||
| Pubmed | Alteration of RANKL-induced osteoclastogenesis in primary cultured osteoclasts from SERCA2+/- mice. | 1.23e-05 | 3 | 71 | 2 | 19419309 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 11526231 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 15161756 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 15972723 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 26461521 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 16754798 | ||
| Pubmed | Coordinate regulation of SR Ca(2+)-ATPase and phospholamban expression in developing murine heart. | 1.23e-05 | 3 | 71 | 2 | 9038922 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 22466636 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 12032137 | ||
| Pubmed | Lack of nitric oxide synthase depresses ion transporting enzyme function in cardiac muscle. | 2.46e-05 | 4 | 71 | 2 | 12074580 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 9295312 | ||
| Pubmed | SERCA1a can functionally substitute for SERCA2a in the heart. | 2.46e-05 | 4 | 71 | 2 | 9887021 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 10555147 | ||
| Pubmed | SERCA2b and 3 play a regulatory role in store-operated calcium entry in human platelets. | 2.46e-05 | 4 | 71 | 2 | 18068335 | |
| Pubmed | 2.87e-05 | 29 | 71 | 3 | 15071553 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 30299255 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 18700007 | ||
| Pubmed | 6.00e-05 | 202 | 71 | 5 | 24639526 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 6.53e-05 | 38 | 71 | 3 | 30786075 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 7.05e-05 | 497 | 71 | 7 | 36774506 | |
| Pubmed | 8.23e-05 | 216 | 71 | 5 | 31519766 | ||
| Pubmed | Genome-wide association study reveals two new risk loci for bipolar disorder. | 1.14e-04 | 8 | 71 | 2 | 24618891 | |
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 27967605 | ||
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 11784029 | ||
| Pubmed | 1.19e-04 | 541 | 71 | 7 | 14983052 | ||
| Pubmed | 1.45e-04 | 129 | 71 | 4 | 23022380 | ||
| Pubmed | Identification of novel germline polymorphisms governing capecitabine sensitivity. | 1.47e-04 | 9 | 71 | 2 | 22864933 | |
| Pubmed | 1.47e-04 | 9 | 71 | 2 | 15253893 | ||
| Pubmed | 1.87e-04 | 407 | 71 | 6 | 12693553 | ||
| Pubmed | 2.23e-04 | 11 | 71 | 2 | 12122109 | ||
| Pubmed | Regulation of membrane fluidity by RNF145-triggered degradation of the lipid hydrolase ADIPOR2. | 2.97e-04 | 63 | 71 | 3 | 35993436 | |
| Pubmed | 2.99e-04 | 285 | 71 | 5 | 34369648 | ||
| Pubmed | 4.06e-04 | 169 | 71 | 4 | 31462741 | ||
| Pubmed | A gene-driven ENU-based approach to generating an allelic series in any gene. | 4.24e-04 | 15 | 71 | 2 | 15457338 | |
| Pubmed | Differentially expressed genes in the lens of mimecan-null mice. | 5.48e-04 | 17 | 71 | 2 | 15215744 | |
| Pubmed | 5.48e-04 | 17 | 71 | 2 | 22411552 | ||
| Pubmed | Genome-wide association of mood-incongruent psychotic bipolar disorder. | 6.16e-04 | 18 | 71 | 2 | 23092984 | |
| Pubmed | 6.16e-04 | 18 | 71 | 2 | 22522309 | ||
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 6.66e-04 | 340 | 71 | 5 | 11875048 | |
| Pubmed | 6.66e-04 | 340 | 71 | 5 | 11802173 | ||
| Pubmed | 6.87e-04 | 19 | 71 | 2 | 25342443 | ||
| Pubmed | 6.93e-04 | 343 | 71 | 5 | 32295537 | ||
| Pubmed | 7.20e-04 | 346 | 71 | 5 | 14611657 | ||
| Pubmed | 7.47e-04 | 529 | 71 | 6 | 14621295 | ||
| Pubmed | 7.62e-04 | 20 | 71 | 2 | 18978355 | ||
| Pubmed | 9.24e-04 | 22 | 71 | 2 | 35081489 | ||
| Pubmed | 1.01e-03 | 23 | 71 | 2 | 19047410 | ||
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | 1.07e-03 | 219 | 71 | 4 | 12213199 | |
| Pubmed | Widespread and dynamic translational control of red blood cell development. | 1.21e-03 | 102 | 71 | 3 | 27899360 | |
| Pubmed | 1.21e-03 | 102 | 71 | 3 | 21926972 | ||
| Pubmed | 1.25e-03 | 103 | 71 | 3 | 21706016 | ||
| Pubmed | 1.29e-03 | 26 | 71 | 2 | 35961308 | ||
| Pubmed | 1.47e-03 | 604 | 71 | 6 | 38803224 | ||
| Pubmed | 1.84e-03 | 31 | 71 | 2 | 16140986 | ||
| Cytoband | 10q11.23 | 1.21e-03 | 33 | 71 | 2 | 10q11.23 | |
| GeneFamily | ATPases Ca2+ transporting | 1.86e-06 | 9 | 52 | 3 | 1209 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 2.88e-04 | 9 | 52 | 2 | 1230 | |
| GeneFamily | Rhomboid family | 7.22e-04 | 14 | 52 | 2 | 926 | |
| GeneFamily | Apolipoproteins | 1.65e-03 | 21 | 52 | 2 | 405 | |
| GeneFamily | ArfGAPs | 4.05e-03 | 33 | 52 | 2 | 395 | |
| GeneFamily | Olfactory receptors, family 1 | 5.90e-03 | 40 | 52 | 2 | 147 | |
| GeneFamily | Olfactory receptors, family 4 | 6.08e-03 | 129 | 52 | 3 | 151 | |
| GeneFamily | WD repeat domain containing | 6.77e-03 | 262 | 52 | 4 | 362 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.42e-06 | 166 | 70 | 5 | 6e6075d0c913e2516083f6dcab21d5878bcef7a4 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-plasmacytoid_dendritic_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.42e-06 | 166 | 70 | 5 | 1ca888ae8168707493f19ee52a89d7c70e6cb51d | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.42e-06 | 166 | 70 | 5 | 4fbe44e0aea197893614cd55f83119aa0f73ee53 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.42e-06 | 166 | 70 | 5 | 4cba4ca1aa2321b9ef7cd230932b890d2434a252 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.30e-05 | 192 | 70 | 5 | 8dc3016601148243196e925641c9507e9d58c9e0 | |
| Drug | alpha-naphthylthiourea | 2.09e-07 | 84 | 69 | 6 | CID000736366 | |
| Drug | verapamil | KCNT2 MYO3B KCNK6 APOD ATP2A1 ATP2A2 ATP2A3 CHRFAM7A ADCY2 TOP2B | 2.12e-06 | 490 | 69 | 10 | CID000002520 |
| Drug | ATP-EDC | 3.15e-06 | 10 | 69 | 3 | CID000195647 | |
| Drug | 1sqc | 3.15e-06 | 10 | 69 | 3 | CID000444279 | |
| Drug | 2,5-dimethylquinone | 4.32e-06 | 11 | 69 | 3 | CID000008718 | |
| Drug | PST-2744 | 5.75e-06 | 12 | 69 | 3 | CID009841834 | |
| Drug | 1vyq | 5.75e-06 | 12 | 69 | 3 | CID004369390 | |
| Drug | p-hydroxyhippuric acid | 9.47e-06 | 14 | 69 | 3 | CID000151012 | |
| Drug | NSC239129 | 1.18e-05 | 15 | 69 | 3 | CID000084597 | |
| Drug | AC1L88YH | 1.76e-05 | 17 | 69 | 3 | CID000374551 | |
| Drug | acetazolamide | 1.85e-05 | 107 | 69 | 5 | CID000001986 | |
| Drug | cisapride | 2.30e-05 | 112 | 69 | 5 | CID000002769 | |
| Drug | AC1L380G | 2.49e-05 | 19 | 69 | 3 | CID000084698 | |
| Drug | methyl phosphate | 2.93e-05 | 20 | 69 | 3 | CID000013130 | |
| Drug | CC270 | 3.10e-05 | 59 | 69 | 4 | CID006918852 | |
| Drug | nsc25485 | 4.42e-05 | 312 | 69 | 7 | CID000004605 | |
| Drug | AC1L25Y6 | 4.52e-05 | 23 | 69 | 3 | CID000015465 | |
| Drug | lanthanum chloride hydrate | 4.52e-05 | 23 | 69 | 3 | CID000165791 | |
| Drug | propranolol | 4.94e-05 | 434 | 69 | 8 | CID000004946 | |
| Drug | quindine | 5.35e-05 | 219 | 69 | 6 | CID000001065 | |
| Drug | trifluoperazine | 5.61e-05 | 324 | 69 | 7 | CID000005566 | |
| Drug | EUK-8 | 5.84e-05 | 25 | 69 | 3 | CID000171249 | |
| Drug | cyhexatin | 5.84e-05 | 25 | 69 | 3 | CID005364545 | |
| Drug | Pyrethroids | 6.44e-05 | 71 | 69 | 4 | CID000005053 | |
| Drug | dodecyl ether | 6.59e-05 | 26 | 69 | 3 | CID000020667 | |
| Drug | monobromobimane | 6.80e-05 | 72 | 69 | 4 | CID000114810 | |
| Drug | octaethylene glycol | 9.20e-05 | 29 | 69 | 3 | CID000078798 | |
| Drug | Bay K 8644 | 9.29e-05 | 150 | 69 | 5 | CID000002303 | |
| Drug | DCCD | 9.59e-05 | 151 | 69 | 5 | CID000010868 | |
| Drug | I-Q-S | 1.12e-04 | 156 | 69 | 5 | CID000003540 | |
| Drug | epicholesterol | MBTPS2 DHCR24 APOL4 APOD ATP2A1 ATP2A2 ATP2A3 CHRFAM7A ADCY2 | 1.24e-04 | 636 | 69 | 9 | CID000000304 |
| Drug | calmidazolium chloride | 1.26e-04 | 160 | 69 | 5 | CID000002531 | |
| Drug | 2-(aminomethyl)pyrrolidine | 1.30e-04 | 161 | 69 | 5 | CID000072032 | |
| Drug | BE-10988 | 1.35e-04 | 6 | 69 | 2 | CID000126200 | |
| Drug | xenon | 1.49e-04 | 88 | 69 | 4 | CID000023991 | |
| Drug | fluorescamine | 1.63e-04 | 35 | 69 | 3 | CID000037927 | |
| Drug | RA-V | 1.63e-04 | 35 | 69 | 3 | CID000476891 | |
| Drug | AC1L1IIA | 1.77e-04 | 172 | 69 | 5 | CID000004591 | |
| Drug | mag-fura-2 | 1.92e-04 | 37 | 69 | 3 | CID000123839 | |
| Drug | gramicidin s | 1.92e-04 | 37 | 69 | 3 | CID000073357 | |
| Drug | potassium | KCNT2 PIK3C2B KCNK6 LRBA DMPK ATP2A1 ATP2A2 ATP2A3 CHRFAM7A ADCY2 BRAP | 2.10e-04 | 1008 | 69 | 11 | CID000000813 |
| Disease | Brody myopathy (implicated_via_orthology) | 1.07e-08 | 3 | 66 | 3 | DOID:0050692 (implicated_via_orthology) | |
| Disease | Central hypothyroidism | 2.95e-05 | 4 | 66 | 2 | C0271801 | |
| Disease | heart disease (implicated_via_orthology) | 8.53e-05 | 38 | 66 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | Motor retardation | 1.76e-04 | 9 | 66 | 2 | C0424230 | |
| Disease | outer ear morphology trait | 3.21e-04 | 12 | 66 | 2 | EFO_0007664 | |
| Disease | Malignant neoplasm of breast | 6.23e-04 | 1074 | 66 | 9 | C0006142 | |
| Disease | Myeloid Leukemia | 7.37e-04 | 18 | 66 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 7.37e-04 | 18 | 66 | 2 | C0023466 | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 7.37e-04 | 18 | 66 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | dense area measurement, mammographic density measurement | 8.22e-04 | 19 | 66 | 2 | EFO_0005941, EFO_0006503 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CIIQLFHVDFAWILA | 136 | P05090 | |
| GVQENLWICLICGHI | 321 | Q7Z569 | |
| LLKIFVVCIWVQQNH | 6 | Q9BPW4 | |
| ALLCQFGTVQHVWKV | 21 | Q8N6Q3 | |
| LICVAVWLINIGHFN | 266 | O14983 | |
| VICVAVWVINIGHFA | 266 | Q93084 | |
| QFHTGIEIKVWAIAC | 441 | Q9UKV8 | |
| WHLVALLGVVVTVCF | 171 | Q9Y257 | |
| LFCFELVLQNAWQLH | 956 | P0DP91 | |
| NLLVLCLFLVWQVRH | 41 | C9J442 | |
| SWVFLVVILQGVQCE | 6 | A0A0B4J1Y9 | |
| VFLLFLDCVWQLVHQ | 451 | Q9C0I1 | |
| LTCLGLVVFNWKLHQ | 306 | A6NM62 | |
| QLACLLEWGQTFVFH | 931 | Q2LD37 | |
| CVGLVILSWIVGIFH | 141 | Q96R72 | |
| LGIIVLIFWDSCLHN | 41 | Q8NH48 | |
| WHLLTNFICVAIFLN | 176 | O14626 | |
| ICNNEGLTAIHWLAV | 126 | Q8IYU2 | |
| LLHVRNGAWFLCLLV | 201 | Q9H0H0 | |
| IQVVFGHWDVVTCLA | 2631 | P50851 | |
| NLFVPVFLNCWLAKH | 161 | Q6UVM3 | |
| ITIIIWLFFLQCCIH | 436 | Q96P66 | |
| VLQGVTHAAIWAACI | 541 | Q6ZSS7 | |
| CVHNIIVGKLWIEQY | 711 | Q9BXW6 | |
| QFQLLIQHLWIAANC | 11 | Q494W8 | |
| CIGLVAHAGQLTAVW | 606 | Q09013 | |
| WIIFGFILCHGILNT | 261 | Q9Y2A7 | |
| IHQLCALLVTGSWVV | 136 | Q96R84 | |
| FHLIVWDQQICFPVQ | 681 | O00750 | |
| LVGNTLVCLAVWRNH | 61 | O43613 | |
| HELWYFVVIQVCNGL | 141 | Q8TED4 | |
| HLVWQILANVIIFIC | 186 | Q08462 | |
| LICIAVWIINIGHFN | 266 | P16615 | |
| CNVNILCHGWLQDLV | 146 | Q8N6C5 | |
| VLIHQRWVFVCLFLL | 26 | Q15392 | |
| QLCTWVGELFLELHN | 506 | Q9NTJ4 | |
| QQLRIFCAGIWHNFV | 216 | O43462 | |
| WLINFVIALGQCALA | 466 | Q8NCS7 | |
| ACFTHNCWVLEGIII | 666 | P26927 | |
| CVQLVAGLWLVTYLH | 141 | Q15619 | |
| VWLLCAVNTAIHTGL | 166 | Q8NGR1 | |
| AWVGSCVHSLVQIFL | 146 | Q8NGL9 | |
| LGLIQQHQHLCVFWT | 256 | Q9Y6K5 | |
| QVKNHIWVFINCLIE | 376 | Q02880 | |
| GFFVWTALLITCHQI | 51 | Q9Y519 | |
| CGLLRFQHLQAWETV | 816 | Q7Z494 | |
| SLICVGLNEQVLHLW | 656 | Q96HU1 | |
| GLNEQVLHLWLEVLC | 661 | Q96HU1 | |
| LVAFHLGLLFVWLCQ | 66 | Q9UBP0 | |
| WLGAEAVCIINFQHL | 1276 | Q8N3C0 | |
| VGWQQECHLGTLRFL | 76 | Q9Y3P4 | |
| VNVVGLLIFQDCAAW | 126 | Q6XR72 | |
| CIQLVFALWLGGTVH | 141 | Q8NGC2 | |
| WNIGVFICIRCAGIH | 41 | Q8WU79 | |
| ELQPHGLVNCNWLFL | 36 | Q9NR96 | |
| CVFWLNIAAALIQIL | 91 | Q69YW2 | |
| RILKVLWCFLIHVQG | 706 | Q9Y2I1 | |
| LWCFLIHVQGSIRQF | 711 | Q9Y2I1 | |
| IGTLVHNSCWLIQAF | 1371 | Q9H5I5 | |
| LLACGQWHHLAVVVT | 1156 | Q6ZS81 | |
| WNIGVFICIRCAGIH | 46 | Q8IYB5 | |
| AQVWLEQVCAHLGLG | 246 | Q6XQN6 | |
| CQNAVIVILILAWEG | 916 | O43151 | |
| GLLQVFWGQEHLNCL | 2241 | Q7Z7G8 | |
| HAVKNDFQIWRLICG | 46 | Q8NBM4 | |
| QWLACGLANHLLLVF | 526 | A2RRH5 | |
| GVCVFILAIIGILHW | 576 | Q8TB96 | |
| FIHCGVVLARLWKNV | 2416 | O15050 | |
| WQGLIAYGCHSLVVV | 31 | Q9BZH6 | |
| CWILNTLVNITVLLH | 136 | Q9BXE9 | |
| LGLVCVTQAGIYWVH | 461 | Q9UN76 | |
| LLLCLNLFVAQVHWH | 166 | A6NGA9 | |
| LCQFLIVATNGLWEV | 446 | A8MPX8 | |
| EVGFLFHCWVRLINL | 141 | Q8N5Q1 | |
| HCVGGQLWLVLELCN | 96 | Q8WXR4 |